Peripheral Blood S100B Levels in Autism Spectrum Disorder: A Systematic Review and Meta-Analysis

  • PDF / 1,126,841 Bytes
  • 9 Pages / 595.276 x 790.866 pts Page_size
  • 97 Downloads / 180 Views

DOWNLOAD

REPORT


ORIGINAL PAPER

Peripheral Blood S100B Levels in Autism Spectrum Disorder: A Systematic Review and Meta‑Analysis Zhen Zheng1   · Peng Zheng2 · Xiaobing Zou1

© The Author(s) 2020

Abstract The S100 calcium-binding protein beta subunit (S100B) protein, which mostly exists in the central nervous system, is commonly noted as a marker of neuronal damage. We conducted the first systematic review with meta-analysis to compare peripheral blood S100B levels in individuals with ASD with those in healthy controls. A systematic search was carried out for studies published before May 5, 2020. In total, this meta-analysis involved ten studies with 822 participants and 451 cases. The meta-analysis revealed that individuals with ASD had higher peripheral blood S100B levels than healthy controls [standardized mean difference (SMD) = 0.97, 95% confidence interval (95% CI) = 0.41–1.53; p